Bank of New York Mellon Corp reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,512,681 shares of the medical equipment provider’s stock after selling 101,352 shares during the period. Bank of New York Mellon Corp owned about 4.07% of Intuitive Surgical worth $1,414,916,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in ISRG. D. Scott Neal Inc. bought a new position in shares of Intuitive Surgical during the second quarter worth about $120,000. Guardian Life Insurance Co. of America increased its position in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares during the last quarter. Parallel Advisors LLC increased its position in shares of Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock worth $129,000 after buying an additional 14 shares during the last quarter. Huntington National Bank increased its position in shares of Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock worth $130,000 after buying an additional 21 shares during the last quarter. Finally, Main Street Research LLC bought a new position in shares of Intuitive Surgical during the second quarter worth about $218,000. 96.08% of the stock is owned by institutional investors.
Shares of Intuitive Surgical, Inc. (ISRG) opened at 985.37 on Wednesday. The stock has a market capitalization of $36.61 billion, a PE ratio of 47.20 and a beta of 0.39. The company’s 50 day moving average price is $942.88 and its 200 day moving average price is $840.08. Intuitive Surgical, Inc. has a 12 month low of $610.71 and a 12 month high of $990.44. Intuitive Surgical’s stock is going to split on Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly minted shares will be issued to shareholders after the closing bell on Wednesday, August 30th.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.79 by $0.16. The firm had revenue of $756.20 million during the quarter, compared to analysts’ expectations of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. Intuitive Surgical’s revenue was up 12.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.62 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post $23.92 earnings per share for the current fiscal year.
A number of research analysts have issued reports on the company. Vetr downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $1,006.51 price target for the company. in a report on Wednesday. BidaskClub downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. Barclays PLC boosted their price target on Intuitive Surgical from $870.00 to $1,000.00 and gave the company an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. Canaccord Genuity reissued a “hold” rating and issued a $870.00 price target on shares of Intuitive Surgical in a report on Tuesday, July 11th. Finally, J P Morgan Chase & Co reissued an “overweight” rating and issued a $1,050.00 price target on shares of Intuitive Surgical in a report on Friday, July 21st. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $979.79.
In related news, Director Amal M. Johnson sold 1,000 shares of Intuitive Surgical stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $917.27, for a total transaction of $917,270.00. Following the completion of the transaction, the director now directly owns 3,787 shares of the company’s stock, valued at $3,473,701.49. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Gary S. Guthart sold 17,975 shares of Intuitive Surgical stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $937.27, for a total value of $16,847,428.25. Following the transaction, the chief executive officer now directly owns 101,798 shares of the company’s stock, valued at $95,412,211.46. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,065 shares of company stock valued at $31,659,090. 2.50% of the stock is currently owned by insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.